Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen is offering a PhD project commencing 1/1 2011 or soon thereafter. The application deadline is December 1st 2010.
The Faculty of Life Science and Novo Nordisk A/S have recently established a research centre - The Novo Nordisk-LIFE In Vivo Pharmacology Centre (NNLIVPC) - with a total budget of DKK 68 mill covering activities until end 2018. The present positions are part of the new Centre´s activities. The purpose of the research centre is to strengthen the research in experimental pharmacology and toxicology and to increase the output of candidates and PhDs with a strong in vivo pharmacological profile. It is expected that the future PhD fellows will be enrolled in the In Vivo Pharmacology PhD program at LIFE and participate actively in this network. The In Vivo Pharmacology PhD program was established in 2006 as a collaboration between the Faculties of Life Sciences, Pharmaceutical Sciences and Health Sciences at the University of Copenhagen, University of Aarhus, and industrial partners; Novo Nordisk A/S, LEO Pharma and H. Lundbeck A/S.
Obesity, increased visceral fat mass, and liver steatosis (fat in liver) are factors associated with increased risk of developing cardiovascular disease. A common side effect following insulin therapy is weight gain - an issue for patients with type 2 diabetes as they often are obese when starting on insulin therapy. At present, the association between insulin-induced weight gain in type 2 diabetic individuals and the risk of developing cardiovascular disease is unclear.
With this project we wish to i) establish how insulin-induced obesity is associated with visceral fat mass and liver steatosis in an animal model of type 2 diabetes, ii) investigate how such changes are associated with relevant blood and tissue markers of inflammation and cardiovascular disease, and iii) investigate how insulin-induced weight gain in patients with type 2 diabetes is associated with changes in markers of cardiovascular disease.Contact:
Professor Jens Lykkesfeldt
Direct Phone: (+45) 35333163
Ph D Scholarship In Rheumatology, University of Sydney, Australia, 13 days ago
Funding Body: NHMRC Title: PhD Scholarship in Rheumatology Research Areas: Health Sciences Type Postgraduate Research Description: A full-time postgraduate scholarship is available for a suitably ...
Ph D Studentship Mechanisms Underlying The Association Between Dementia And Sleep Wake Cycle Disturbances, University of Surrey, United Kingdom, 16 days ago
View All Vacancies School of Biosciences & Medicine Location: Guildford Post Type: Full Time Advert Placed: Monday 12 September 2016 Closing Date: Monday 10 October 2016 Reference: 068116 Mec...
Ph D Candidate Opportunity, The University of Queensland, Australia, 25 days ago
Apply now Job no:499473 Area:Institute for Molecular Bioscience Salary (FTE):Research Scholar BAND Work type:Full Time - Fixed Term, Full Time - Scholarship Location: St Lucia, Brisbane The Univer...
2 Ph D Positions In Cardiovascular Biomechanics, Eindhoven University of Technology, Netherlands, 7 days ago
The Technische Universiteit Eindhoven (TU/e) has the following PhD vacancies in the group Cardiovascular Biomechanics at the Department of Biomedical Engineering 1. In vitro and in vivo validation...
Ph D Position In Quantitative Systems Pharmacology, France, Université François-Rabelais, France, 16 days ago
Job posted by Université François-Rabelais (13/09/2016 08.58) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code...
2 Ph D Positions In Cardiovascular Biomechanics, Eindhoven University of Technology (TU/e), Netherlands, 5 days ago
Job posted by AcademicTransfer (24/09/2016 03.15) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code for Researc...